NASP Special Webinar: Enhancing Specialty Drug Review and Formulary Insights
Feb 12 · Members in the News

FormularyDecisions | Cencora, in partnership with The National Association of Specialty Pharmacy, is pleased to announce an overview of FormularyDecisions®, an online platform that supports the exchange of information between healthcare decision-makers and biopharma companies to streamline the product review process. This resource provides healthcare decision-makers complimentary access to evidence on more than 3,900 pipeline and FDA-approved products.
Key features – all aimed to enable efficiencies in product review, reimbursement, and contracting decisions – include
- Biosimilar Hub: an industry-recognized resource with an interactive chart of the US market landscape, a repository of state substitution laws, and a biosimilar indication tool
- Formulary Coverage Insights Tool: pharmacy and medical coverage data on formulary placement of hundreds of products
- Product Snapshots: curated pre-approval product information, clinical trial summaries, and P&T considerations created by clinical pharmacists
Click here to register for this webinar.